Gene Logic Inc - Current report filing (8-K)

---

UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

FORM 8-K

CURRENT REPORT

PURSUANT TO SECTION 13 OR 15(D) OF THE
SECURITIES EXCHANGE ACT OF 1934

Date of Report (Date of earliest event reported)
October 15, 2007 (October 15, 2007)

GENE LOGIC INC.
(Exact name of registrant as specified in its charter)

-------------------------------------------------------------------------------- DELAWARE 0-23317 06-1411336 -------------------------------------------------------------------------------- (State of Incorporation) (Commission File Number) (IRS Employer Identification Number) -------------------------------------------------------------------------------- 50 West Watkins Mill Road Gaithersburg, Maryland 20878 (Address of principal executive offices) [phone] (Registrant's telephone number, including area code)

(Former name or former address, if changed since last report)

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:

[ ] Written communications pursuant to Rule 425 under the Securities Act

(17 CFR 230.425)

[ ] Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)

[ ] Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))

[ ] Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

---

---

SECTION 9. FINANCIAL STATEMENTS AND EXHIBITS

Item 9.01. Financial Statements and Exhibits. (c) Exhibits Exhibit Number Description ----------------------------- ---------------------------------------------- 99.1 Press Release issued by Gene Logic Inc. dated October 15, 2007 with respect to the sale of Genomics Assets to Ocimum Biosolutions Ltd.

2

---

SIGNATURE

Pursuant to the requirements of the Securities Exchange Act of 1934, the Registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

GENE LOGIC INC.

Date: October 15, 2007 By: /s/ Philip L. Rohrer, Jr. ---------------------------------------- Philip L. Rohrer, Jr. Chief Financial Officer

3

---

EXHIBIT INDEX

Exhibit Number Description ---------------------- ----------------------------------------------- 99.1 Press release issued by Gene Logic Inc. dated October 15, 2007 with respect to the sale of Genomics Assets to Ocimum Biosolutions Ltd.

4